Family Medicine · Leawood, KS
NPI
1497742886
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
6807 W. 121st St.
Leawood, KS, 66209
Phone (913) 356-1007
Medicare paid, 2024
$6,537
140 services
Medicare patients, 2024
45
Average age 71
Drug cost, 2024
$211K
3,633 prescriptions
Company payments, 2025
$484
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark L Gillett was code 99214 (office e&m - established), 48 times for 34 patients. In total Mark L Gillett billed 140 services in 29 codes, and Medicare paid $6,537.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 48 | 34 | $39.34 | $1,889 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 12 | 12 | $20.21 | $243 |
| 99213 Office E&M - Established | Office | 11 | 11 | $7.35 | $80.84 |
By year: 2022 $34K for 815 services; 2023 $12K for 256 services; 2024 $6,537 for 140 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark L Gillett prescribed most often to Medicare patients was Atorvastatin Calcium, with 211 prescriptions and refills. In total Mark L Gillett wrote 3,633 Medicare prescriptions that cost $211K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 211 | 587 | 67 | $1,881 |
| Levothyroxine Sodium Generic | 175 | 525 | 54 | $1,701 |
| Simvastatin Generic | 159 | 435 | 48 | $769 |
| Lisinopril Generic | 125 | 355 | 37 | $815 |
| Amlodipine Besylate Generic | 110 | 335 | 34 | $673 |
| Losartan Potassium Generic | 108 | 316 | 30 | $941 |
| Tamsulosin Hcl Generic | 99 | 277 | 28 | $1,314 |
| Metoprolol Succinate Generic | 85 | 239 | 24 | $890 |
| Hydrochlorothiazide Generic | 83 | 251 | 24 | $332 |
| Gabapentin Generic | 80 | 164 | 25 | $1,326 |
| Omeprazole Generic | 70 | 192 | 19 | $543 |
| Metformin Hcl Generic | 66 | 188 | 21 | $467 |
| Ezetimibe Generic | 65 | 198 | 20 | $1,151 |
| Ramipril Generic | 64 | 180 | 20 | $489 |
| Potassium Chloride Generic | 60 | 179 | 21 | $1,023 |
Brand drugs: - claims; generic drugs: 3,362 claims; opioid claims: 117.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark L Gillett $484 ($484 in general payments such as food, travel and fees) from 9 companies. The largest payer was Antares Pharma, Inc. with $147.
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 15 | $147 |
| Lilly USA, LLC LLY | 4 | $80.64 |
| Axsome Therapeutics, Inc. AXSM | 3 | $62.13 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $44.63 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $38.51 |
| Pfizer Inc. PFE | 2 | $36.6 |
| Bioventus LLC BVS | 1 | $33.32 |
| Novo Nordisk Inc NVO | 1 | $22.73 |
| Astellas Pharma US Inc 4503.T | 1 | $18.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.